Andrew Coop

5.8k total citations · 1 hit paper
154 papers, 4.6k citations indexed

About

Andrew Coop is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Andrew Coop has authored 154 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Cellular and Molecular Neuroscience, 78 papers in Molecular Biology and 30 papers in Organic Chemistry. Recurrent topics in Andrew Coop's work include Pharmacological Receptor Mechanisms and Effects (53 papers), Neuropeptides and Animal Physiology (50 papers) and Receptor Mechanisms and Signaling (41 papers). Andrew Coop is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (53 papers), Neuropeptides and Animal Physiology (50 papers) and Receptor Mechanisms and Signaling (41 papers). Andrew Coop collaborates with scholars based in United States, United Kingdom and Austria. Andrew Coop's co-authors include Alexander D. MacKerell, Matthew J. Ellis, William R. Miller, F. Jänicke, Erhard Quebe‐Fehling, Dean B. Evans, L. Mauriac, James E. Polli, Baljit Singh and Dean Y. Maeda and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Andrew Coop

152 papers receiving 4.5k citations

Hit Papers

Letrozole Is More Effective Neoadjuvant Endocrine Therapy... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Coop United States 32 1.9k 1.5k 1.1k 693 599 154 4.6k
Kevin R. Kozak United States 36 929 0.5× 404 0.3× 797 0.7× 597 0.9× 244 0.4× 89 4.5k
Gregory R. J. Thatcher United States 38 2.1k 1.1× 290 0.2× 491 0.4× 258 0.4× 730 1.2× 195 5.1k
Valerie G. Montana United States 17 3.5k 1.8× 621 0.4× 449 0.4× 359 0.5× 1.2k 2.0× 18 4.9k
Abdul H. Fauq United States 45 3.0k 1.5× 734 0.5× 749 0.7× 356 0.5× 250 0.4× 121 5.7k
Thomas D. Hurley United States 48 3.9k 2.1× 295 0.2× 813 0.7× 1.1k 1.6× 396 0.7× 114 7.2k
Stefanie D. Krämer Switzerland 40 2.1k 1.1× 538 0.4× 762 0.7× 209 0.3× 132 0.2× 172 4.4k
María L. López-Rodrı́guez Spain 39 2.2k 1.1× 2.0k 1.3× 227 0.2× 405 0.6× 190 0.3× 191 5.4k
Antonio Macchiarulo Italy 36 2.7k 1.4× 278 0.2× 2.3k 2.1× 203 0.3× 331 0.6× 173 6.4k
W. Gibson Wood United States 45 3.0k 1.6× 696 0.5× 398 0.4× 315 0.5× 82 0.1× 106 5.1k
Brenda C. Crews United States 35 1.2k 0.6× 258 0.2× 417 0.4× 321 0.5× 583 1.0× 84 4.6k

Countries citing papers authored by Andrew Coop

Since Specialization
Citations

This map shows the geographic impact of Andrew Coop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Coop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Coop more than expected).

Fields of papers citing papers by Andrew Coop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Coop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Coop. The network helps show where Andrew Coop may publish in the future.

Co-authorship network of co-authors of Andrew Coop

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Coop. A scholar is included among the top collaborators of Andrew Coop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Coop. Andrew Coop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilkerson, Jenny L., et al.. (2019). The Effects of Morphine, Baclofen, and Buspirone Alone and in Combination on Schedule-Controlled Responding and Hot Plate Antinociception in Rats. Journal of Pharmacology and Experimental Therapeutics. 370(3). 380–389. 6 indexed citations
2.
Stavitskaya, Lidiya, et al.. (2013). Effect of ring-constrained phenylpropyloxyethylamines on sigma receptors. Bioorganic & Medicinal Chemistry. 21(17). 4923–4927. 3 indexed citations
3.
Robson, Matthew J., Michael J. Seminerio, Christopher R. McCurdy, Andrew Coop, & Rae R. Matsumoto. (2013). σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Pharmacological Reports. 65(2). 343–349. 11 indexed citations
4.
Pouw, Buddy, et al.. (2013). Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands. Bioorganic & Medicinal Chemistry Letters. 23(24). 6920–6922. 3 indexed citations
5.
McKnight, Laura E., E. Prabhu Raman, Paul T. Wilder, et al.. (2012). Structure-Based Discovery of a Novel Pentamidine-Related Inhibitor of the Calcium-Binding Protein S100B. ACS Medicinal Chemistry Letters. 3(12). 975–979. 20 indexed citations
6.
Stavitskaya, Lidiya, et al.. (2010). The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands. Bioorganic & Medicinal Chemistry Letters. 20(8). 2564–2565. 3 indexed citations
7.
Koek, Wouter, Susan L. Mercer, Andrew Coop, & Charles P. France. (2009). Behavioral Effects of γ-Hydroxybutyrate, Its Precursor γ-Butyrolactone, and GABAB Receptor Agonists: Time Course and Differential Antagonism by the GABAB Receptor Antagonist 3-Aminopropyl(diethoxymethyl)phosphinic Acid (CGP35348). Journal of Pharmacology and Experimental Therapeutics. 330(3). 876–883. 16 indexed citations
8.
Coop, Andrew, et al.. (2007). 3-Hydroxy-4-methoxyindolomorphinans as delta opioid selective ligands. Bioorganic & Medicinal Chemistry Letters. 17(18). 5175–5176. 10 indexed citations
9.
Wu, Huifang, et al.. (2007). Functionalization of the 6,14-bridge of the orvinols. Part 3: Preparation and pharmacological evaluation of 18- and 19-hydroxyl substituted orvinols. Bioorganic & Medicinal Chemistry Letters. 17(17). 4829–4831. 3 indexed citations
10.
Fantegrossi, William E., J.R. Eckler, Richard A. Rabin, et al.. (2005). Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology. 181(3). 496–503. 61 indexed citations
11.
Coop, Andrew, et al.. (2004). SNC 80 and Related δ Opioid Agonists. Current Pharmaceutical Design. 10(7). 733–742. 15 indexed citations
12.
Hong, Wu, et al.. (2004). The Discriminative Stimulus Effects of γ-Hydroxybutyrate and Related Compounds in Rats Discriminating Baclofen or Diazepam: The Role of GABAB and GABAA Receptors. Journal of Pharmacology and Experimental Therapeutics. 309(2). 540–547. 21 indexed citations
13.
Koek, Wouter, L R Flores, R. J. Lamb, et al.. (2004). Discriminative Stimulus Effects of γ-Hydroxybutyrate in Pigeons: Role of Diazepam-Sensitive and -Insensitive GABAA and GABAB Receptors. Journal of Pharmacology and Experimental Therapeutics. 308(3). 904–911. 30 indexed citations
14.
Fantegrossi, William E., Gail Winger, J H Woods, W. L. Woolverton, & Andrew Coop. (2004). Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug and Alcohol Dependence. 77(2). 161–168. 52 indexed citations
15.
Ellis, Matthew J., Andrew Coop, Baljit Singh, et al.. (2003). Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.. PubMed. 63(19). 6523–31. 167 indexed citations
16.
Foster, Abby, Huifang Wu, Weibin Chen, et al.. (2003). 1,4-Dibenzylpiperazines possess anticocaine activity. Bioorganic & Medicinal Chemistry Letters. 13(4). 749–751. 27 indexed citations
17.
May, Everette L., Andrew Coop, James H. Woods, et al.. (2003). N-(Trifluoromethyl)benzyl substituted N-Normetazocines and N-Norketobemidones. Bioorganic & Medicinal Chemistry. 11(1). 31–33. 2 indexed citations
18.
Maeda, Dean Y., et al.. (2002). N-Arylalkylpiperidines as High-Affinity Sigma-1 and Sigma-2 Receptor Ligands: Phenylpropylamines as Potential Leads for Selective Sigma-2 Agents. Bioorganic & Medicinal Chemistry Letters. 12(3). 497–500. 31 indexed citations
19.
Hsin, Ling‐Wei, Xinrong Tian, Elizabeth Webster, et al.. (2002). CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists. Bioorganic & Medicinal Chemistry. 10(1). 175–183. 32 indexed citations
20.
Coop, Andrew, et al.. (1999). Delta opioid binding selectivity of 3-ether analogs of naltrindole. Bioorganic & Medicinal Chemistry Letters. 9(24). 3435–3438. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026